Klett C, Bader M, Schwemmle M, Ganten D, Hackenthal E
Department of Pharmacology, University of Heidelberg, Germany.
J Mol Endocrinol. 1995 Apr;14(2):209-26. doi: 10.1677/jme.0.0140209.
Several authors have shown that angiotensin II stimulates hepatic angiotensinogen synthesis in vivo, ex vivo and in vitro. In previous studies we have demonstrated that this effect of angiotensin II depends mainly on a transient inhibition of adenylyl cyclase and is the consequence of a stabilization of angiotensinogen mRNA. In the present study we describe the isolation of a polysomal 12 kDa protein which, in band shift and cross link assays, shows a specific affinity to the 3' untranslated region (3' UTR) of angiotensinogen mRNA and prevents enzymatic degradation of angiotensinogen mRNA in a cell-free incubation system. [32P]UTP-labelled or unlabelled 3' fragments of angiotensinogen mRNA were synthesized on a transcription vector (pGEM5zf+) into which the corresponding DNA sequence was cloned after restriction from vector pRAG 16. Binding of the 12 kDa protein to the radioactively labelled 3' UTR of angiotensinogen mRNA could be displaced by unlabelled 3' UTR mRNA fragments but not by a renin mRNA of comparable length derived from the coding region. The RNA-binding protein appears to be derived from a higher molecular mass precursor (45 kDa) which is preferentially present under reducing conditions in vitro; the active low molecular mass form is evident in the absence of reducing agents. In a cross link experiment we established that a band shift signal which was obtained in the presence of the 45 kDa protein preparation exclusively depends on RNA binding of the active 12 kDa protein. In addition, a phosphorylation step may be involved in the activation of the 12 kDa protein, since its molecular mass and isoelectric point correlate with proteins which were phosphorylated in response to transient decreases of cAMP (induced by guanfacine or angiotensin II) or in response to a direct inhibition of protein kinase A by the cAMP antagonist Rp-cAMP. The importance of phosphorylation reactions for the stabilization of angiotensinogen mRNA was further assessed in a cell-free incubation system of rat liver parenchymal cells. These studies demonstrated that in the presence of acid phosphatase (1 U/ml) the half-life of angiotensinogen was significantly decreased. In the same incubation system the 12 kDa protein increased the half-life of endogenous as well as of exogenous angiotensinogen mRNA three- to fourfold, while no stabilizing effect was apparent when exogenous angiotensinogen mRNA from which the 3' tail had been deleted was added.(ABSTRACT TRUNCATED AT 400 WORDS)
几位作者已表明,血管紧张素II在体内、体外和离体条件下均能刺激肝脏血管紧张素原的合成。在先前的研究中,我们已证明血管紧张素II的这种作用主要依赖于对腺苷酸环化酶的短暂抑制,并且是血管紧张素原mRNA稳定性增加的结果。在本研究中,我们描述了一种多聚核糖体12 kDa蛋白的分离,该蛋白在凝胶迁移和交联试验中显示出对血管紧张素原mRNA的3'非翻译区(3'UTR)具有特异性亲和力,并能在无细胞孵育系统中防止血管紧张素原mRNA的酶促降解。血管紧张素原mRNA的[32P]UTP标记或未标记的3'片段在转录载体(pGEM5zf+)上合成,在从载体pRAG 16进行限制性酶切后,将相应的DNA序列克隆到该载体中。12 kDa蛋白与血管紧张素原mRNA放射性标记的3'UTR的结合可被未标记的3'UTR mRNA片段取代,但不能被来自编码区的长度相当的肾素mRNA取代。这种RNA结合蛋白似乎来源于一种分子量更高的前体(45 kDa),该前体在体外还原条件下优先存在;在没有还原剂的情况下,活性低分子量形式明显可见。在交联实验中,我们确定在存在45 kDa蛋白制剂的情况下获得的凝胶迁移信号完全取决于活性12 kDa蛋白的RNA结合。此外,磷酸化步骤可能参与12 kDa蛋白的激活,因为其分子量和等电点与因cAMP短暂降低(由胍法辛或血管紧张素II诱导)或因cAMP拮抗剂Rp-cAMP直接抑制蛋白激酶A而发生磷酸化的蛋白相关。在大鼠肝实质细胞的无细胞孵育系统中进一步评估了磷酸化反应对血管紧张素原mRNA稳定性的重要性。这些研究表明,在存在酸性磷酸酶(1 U/ml)的情况下,血管紧张素原的半衰期显著缩短。在相同的孵育系统中,12 kDa蛋白使内源性和外源性血管紧张素原mRNA的半衰期增加了三到四倍,而当加入缺失3'尾的外源性血管紧张素原mRNA时,没有明显的稳定作用。(摘要截短至400字)